<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04647071</url>
  </required_header>
  <id_info>
    <org_study_id>C002</org_study_id>
    <nct_id>NCT04647071</nct_id>
  </id_info>
  <brief_title>Allium Extracts on the Incidence of Respiratory Infection Symptoms in Healthy Elderly Volunteers</brief_title>
  <official_title>Study of the Effect of the Consumption of a Combination of Allium Extracts on the Incidence of Symptoms of Respiratory Infections in Healthy Elderly Residents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DOMCA S.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>DOMCA S.A.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To analyze the efficacy of daily consumption of a combination of garlic and onion extracts on&#xD;
      the incidence of respiratory infection symptoms in healthy elderly volunteers living in a&#xD;
      residence.&#xD;
&#xD;
      The duration of symptoms and related medication will also be studied.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is a controlled, randomized, double-blind, parallel-group nutritional intervention study.&#xD;
&#xD;
      66 healthy elderly volunteers living in a nursing home will be randomly distributed into 2&#xD;
      equal groups: control group and intervention group.&#xD;
&#xD;
      For 36 weeks the volunteers will take the product immediately after lunch. During that time&#xD;
      they will maintain their lifestyle and nutritional habits.&#xD;
&#xD;
      Every 4 weeks, the medical team of the residence will review the cases of respiratory&#xD;
      diseases of infectious origin of the volunteers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 16, 2020</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Actual">July 26, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Each volunteer is assigned a &quot;participant number&quot; that will be associated with a pot that will have all the product for the study.&#xD;
The &quot;pot number&quot; is the same as the &quot;participant number&quot;. The pot does not indicate which product it is carrying.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of respiratory symptoms associated with infections.</measure>
    <time_frame>36 weeks.</time_frame>
    <description>It will be reviewed if the volunteer has had any symptoms related to respiratory diseases of infectious origin.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of symptoms.</measure>
    <time_frame>36 weeks</time_frame>
    <description>If the volunteer has had any symptoms related to respiratory diseases of infectious origin, every 4 weeks duration of these symptoms will be reviewed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consumption of medicines.</measure>
    <time_frame>36 weeks</time_frame>
    <description>If the volunteer has had any symptoms related to respiratory diseases of infectious origin, every 4 weeks treatment applied will be reviewed.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Immunity</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Microcrystalline cellulose (9892- Capsules®) up to 400 mg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Garlic concentrated extract plus onion concentrated extract plus microcrystalline cellulose (9892- Capsules®) up to 400 mg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Garlic and onion concentrate</intervention_name>
    <description>Garlic extract concentrate (equivalent to 2 garlic cloves) and onion extract concentrate (equivalent to 1 onion).</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>AlioCare</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Microcrystalline cellulose</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>Excipient</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Live in a nursing home with medical services.&#xD;
&#xD;
          -  Accept being vaccinated for the flu.&#xD;
&#xD;
          -  Freely accepted to participate in the study and sign the informed consent document.&#xD;
&#xD;
          -  Have the consent of the family.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Having any disease that affects the development and results of the study.&#xD;
&#xD;
          -  Be unable to understand the study and sign voluntarily and freely the informed&#xD;
             consent.&#xD;
&#xD;
          -  Have a low expectation of compliance with the study protocol.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos Gracián, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Claret Residence for the Elderly (Granada, Spain).</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Residencia de Mayores Claret</name>
      <address>
        <city>Granada</city>
        <zip>18012</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 22, 2020</study_first_submitted>
  <study_first_submitted_qc>November 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 30, 2020</study_first_posted>
  <last_update_submitted>August 19, 2021</last_update_submitted>
  <last_update_submitted_qc>August 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Garlic</keyword>
  <keyword>Onion</keyword>
  <keyword>Immunity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

